This certification is a key milestone in our global strategy to expand access to minimally invasive endoluminal procedures
By | November 5, 2025

The latest news about Lumendi

LUMENDI RECEIVES CE MARK FOR DILUMEN™ EZ¹ AND DILUMEN™ C¹, EXPANDING FOOTPRINT IN THE EUROPEAN MARKET

This certification is a key milestone in our global strategy to expand access to minimally invasive endoluminal procedures

LUMENDI RECEIVES CE MARK FOR DILUMEN™ EZ¹ AND DILUMEN™ C¹, EXPANDING FOOTPRINT IN THE EUROPEAN MARKET

LUMENDI RECEIVES CE MARK FOR DILUMEN™ EZ¹ AND DILUMEN™ C¹, EXPANDING FOOTPRINT IN THE EUROPEAN MARKET ZUG, Switzerland, Oct. 29, 2025 /PRNewswire/  Lumendi AG, a leader in advanced endoluminal technologies, today… Continue reading LUMENDI RECEIVES CE MARK FOR DILUMEN™ EZ¹ AND DILUMEN™ C¹, EXPANDING FOOTPRINT IN THE EUROPEAN MARKET

Experience Innovation in Action: Lumendi Unveils Revolutionary DiLumen Products at the 2024 Kings Live Event in the UK

At the 2024 Kings Live Event, Lumendi showcased the groundbreaking DiLumen EZ Glide system, demonstrating its superior capabilities in advanced endoscopic procedures through live cases led by Dr. Amyn Haji.

EZ¹ successfully completes Customer Evaluation phase.

Lumendi Achieves Key Milestone with Completion of DiLumen EZ¹ Customer Evaluations, Setting the Stage for the Next Phase of DiLumen Product Innovation WESTPORT, CT – July 27, 2023 Lumendi, a… Continue reading EZ¹ successfully completes Customer Evaluation phase.

A successful Digestive Disease Week (DDW) conference in San Diego

Since the company’s inception, we have accumulated over 100 DiLumen users worldwide. Half of these physicians have begun using our devices in the last 12 to 18 months. This year’s DDW was our first opportunity in three years to present Lumendi and our significantly enhanced DiLumen platform to users and industry.

Lumendi receives 510k clearance for two new devices

Company Achieves New Milestone with Over 4,000 Therapeutic Procedures Completed Across the U.S., Europe and Asia, Using DiLumen™ Endoluminal Interventional Platform February 16, 2023 08:00 AM Eastern Standard Time WESTPORT,… Continue reading Lumendi receives 510k clearance for two new devices